Friday, December 20, 2024 | 05:15 AM ISTEN Hindi

Home / Health / iNCOVACC: All you need to know about world's first intranasal Covid vaccine

iNCOVACC: All you need to know about world's first intranasal Covid vaccine

The vaccine been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India

Bharat Biotech’s iNCOVACC, Bharat Bio’s nasal Covid vaccine, nasal Covid vaccine, Covid vaccine

Premium

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus.

BS Web Team New Delhi

2 min read Last Updated : Jan 27 2023 | 5:26 PM IST

India launched its first intranasal Covid-19 vaccine named iNCOVACC, on Thursday, January 26. Manufactured by Hyderabad-based Bharat Biotech, the intranasal vaccine was launched by Union Health Minister Mansukh Mandaviya and Union Minister of Science & Technology Jitendra Singh on India's 74th Republic Day.

The vaccine has been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India.

Here's everything you need to know about India's first intranasal vaccine for coronavirus:

What is iNCOVACC?

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus. According to

Topics : Coronavirus Coronavirus Vaccine Bharat Biotech government of India

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in